Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

Josephine M. Bryant(MRC Laboratory of Molecular Biology), Dorothy Grogono(MRC Laboratory of Molecular Biology), Daniela Rodriguez-Rincon(MRC Laboratory of Molecular Biology), Isobel Everall(Wellcome Sanger Institute), Karen Brown(MRC Laboratory of Molecular Biology), Pablo Moreno(European Bioinformatics Institute), Deepshikha Verma(Colorado State University), Emily Hill(Colorado State University), Judith Drijkoningen(MRC Laboratory of Molecular Biology), Peter H. Gilligan, Charles R. Esther, Peadar G. Noone, Olivia Giddings, Scott C. Bell(The University of Queensland), Rachel Thomson(The University of Queensland), Claire Wainwright(The University of Queensland), Chris Coulter(Victorian Infectious Diseases Reference Laboratory), Sushil Pandey(Victorian Infectious Diseases Reference Laboratory), Michelle Wood(The University of Queensland), Rebecca E. Stockwell(The University of Queensland), Kay A. Ramsay(The University of Queensland), Laura J. Sherrard(QIMR Berghofer Medical Research Institute), Timothy J. Kidd(Queen's University Belfast), Nassib Jabbour(Queensland University of Technology), Graham Johnson(Queensland University of Technology), Luke D. Knibbs(The University of Queensland), Lídia Morawska(Queensland University of Technology), Peter D. Sly(The University of Queensland), Andrew Jones(Royal Brompton & Harefield NHS Foundation Trust), Diana Bilton(Royal Brompton & Harefield NHS Foundation Trust), Ian F. Laurenson(National Library of Scotland), Michael Ruddy(Cardiff Metropolitan University), Stephen Bourke(Newcastle upon Tyne Hospitals NHS Foundation Trust), I.C.J.W. Bowler(Oxford University Hospitals NHS Trust), S. Jonathan Chapman(Oxford University Hospitals NHS Trust), Andrew Clayton(Nottingham University Hospitals NHS Trust), M. Cullen(Manchester University NHS Foundation Trust), Owen Dempsey(Aberdeen Royal Infirmary), Miles Denton(Leeds Teaching Hospitals NHS Trust), Maya Desai(Birmingham Children's Hospital), Richard J. Drew(Alder Hey Children's NHS Foundation Trust), F. Edenborough(Sheffield Teaching Hospitals NHS Foundation Trust), J. C. Evans(Cardiff Metropolitan University), Jonathan Folb(Royal Liverpool and Broadgreen University Hospital NHS Trust), T. Daniels(University Hospital Southampton NHS Foundation Trust), Helen Humphrey(University Hospital Southampton NHS Foundation Trust), B. Isalska(Manchester University NHS Foundation Trust), Søren Jensen‐Fangel(Aarhus University Hospital), Bodil Jönsson(University of Gothenburg), Andrew Jones(Royal Brompton & Harefield NHS Foundation Trust), Terese L. Katzenstein(Rigshospitalet), Troels Lillebæk(Statens Serum Institut), Gordon MacGregor(NHS Greater Glasgow and Clyde), Sarah Mayell(Alder Hey Children's NHS Foundation Trust), Michael Millar(Barts Health NHS Trust), Deborah Modha(University Hospitals of Leicester NHS Trust), E.F. Nash(Heart of England NHS Foundation Trust), Christopher J. O’Brien(Newcastle upon Tyne Hospitals NHS Foundation Trust), Deirdre O’Brien(St. Vincent's University Hospital), Chandra Ohri(University Hospitals of Leicester NHS Trust), C. Pao(Barts Health NHS Trust), D. Peckham(Leeds Teaching Hospitals NHS Trust), Felicity Perrin(King's College Hospital NHS Foundation Trust), Audrey Perry(Newcastle upon Tyne Hospitals NHS Foundation Trust), T. Pressler(Rigshospitalet), Laura Prtak(Sheffield Teaching Hospitals NHS Foundation Trust), Tavs Qvist(Rigshospitalet), A. Robb(Newcastle upon Tyne Hospitals NHS Foundation Trust), Helen Rodgers(NHS Lothian), Kirsten Schaffer(St. Vincent's University Hospital), Nadia Shafi(Papworth Hospital), Jakko van Ingen(Radboud University Nijmegen), Martin Walshaw(University of Liverpool), Danie Watson(Barts Health NHS Trust), N. West(Sheffield Children's NHS Foundation Trust), J.L. Whitehouse(Heart of England NHS Foundation Trust), Charles Haworth(Papworth Hospital), Simon R. Harris(Wellcome Sanger Institute), Diane Ordway(Colorado State University), Julian Parkhill(Wellcome Sanger Institute), R. Andrés Floto(MRC Laboratory of Molecular Biology)
Science
November 11, 2016
Cited by 584

Abstract

Lung infections with Mycobacterium abscessus, a species of multidrug-resistant nontuberculous mycobacteria, are emerging as an important global threat to individuals with cystic fibrosis (CF), in whom M. abscessus accelerates inflammatory lung damage, leading to increased morbidity and mortality. Previously, M. abscessus was thought to be independently acquired by susceptible individuals from the environment. However, using whole-genome analysis of a global collection of clinical isolates, we show that the majority of M. abscessus infections are acquired through transmission, potentially via fomites and aerosols, of recently emerged dominant circulating clones that have spread globally. We demonstrate that these clones are associated with worse clinical outcomes, show increased virulence in cell-based and mouse infection models, and thus represent an urgent international infection challenge.


Related Papers

No related papers found

Powered by citation graph analysis